Ulf Mark Schneider

He joined Fresenius, a diversified global health care group, in 2001 and has served as CEO since 2003. Previously he was group finance director of the U.K.-based pharmaceutical distributor Gehe UK.

  • 2014 Fourth Quarter

Added to: DuPont de Nemours Inc. - Wilmington, DE

Dupont is a global science and technology company. Revenues are $20 billion.